2011-02-08-Bain-Creating_a_new_commercial_model_for_the_changing_medtech_market_4页_210kb

Healthcare Medtech Market Analysis Summary

The medtech industry is facing significant shifts due to increased economic factors in device selection and reduced clinical differentiation, leading to pressure on pricing and margins. Key recommendations include segmenting the market, tailoring sales approaches, and aligning the organization.

Market Changes and Segmentation

• Economic influences now play a larger role in device decisions, with CFOs and purchasers focusing on total cost, reducing product margins.
• Clinical differentiation is diminishing in high-profit areas like cardiology and orthopedics, affecting innovation hurdles.
• Segmentation is critical based on two dimensions: device selection criteria (clinical vs economic) and account sophistication (naive vs sophisticated).

Tailored Go-to-Market Strategies

• Price Negotiators: Focus on cost reduction through unbundled pricing, all-play bids, and bargaining for lower device costs.
• Traditional Physician Preference Accounts: Emphasize clinical outcomes and flexible product offerings to maintain influence.
• Collaborative Buyers: Integrate services to reduce total healthcare costs, including inventory and OR utilization, through partnership models.

Organizational Alignment and Transformation

• Realign sales and marketing capabilities, such as adjusting call points and redefining roles like incorporating clinical support and financial partnerships.
• Improve customer relationship management (CRM) systems to track buyer needs.
• Invest in competitor intelligence and risk-sharing programs to enhance market positioning.
• Coordinate transformation efforts across dimensions, including data access and scalability, to avoid failure in adapting to new dynamics.

Failure to evolve can lead to incremental decline or rapid market loss, with industry profitability and share expected to reshuffle over the next few years.